66 related articles for article (PubMed ID: 22907763)
21. Meta-analysis of percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with diabetes and left main and/or multivessel coronary artery disease.
Gao F; Zhou YJ; Shen H; Wang ZJ; Yang SW; Liu XL
Acta Diabetol; 2013 Oct; 50(5):765-73. PubMed ID: 22907763
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease.
De Luca G; Schaffer A; Verdoia M; Suryapranata H
Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):344-54. PubMed ID: 24373711
[TBL] [Abstract][Full Text] [Related]
23. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.
Sipahi I; Akay MH; Dagdelen S; Blitz A; Alhan C
JAMA Intern Med; 2014 Feb; 174(2):223-30. PubMed ID: 24296767
[TBL] [Abstract][Full Text] [Related]
24. Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trial.
Burgess SN; Mussap CJ; French JK
Clin Ther; 2013 Aug; 35(8):1069-75. PubMed ID: 23973040
[TBL] [Abstract][Full Text] [Related]
25. Coronary artery bypass graft surgery remains the standard of care for patients with diabetes.
Moss E; Alam M; Ballantyne CM; Puskas JD
Semin Thorac Cardiovasc Surg; 2013; 25(2):97-9. PubMed ID: 24216525
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in the treatment of diabetic patients with multi-vessel coronary disease: a meta-analysis.
Zhang F; Yang Y; Hu D; Lei H; Wang Y
Diabetes Res Clin Pract; 2012 Aug; 97(2):178-84. PubMed ID: 22513345
[TBL] [Abstract][Full Text] [Related]
27. Effect of increasing age on percutaneous coronary intervention vs coronary artery bypass grafting in older adults with unprotected left main coronary artery disease: A meta-analysis and meta-regression.
Khan MR; Kayani WT; Ahmad W; Manan M; Hira RS; Hamzeh I; Jneid H; Virani SS; Kleiman N; Lakkis N; Alam M
Clin Cardiol; 2019 Nov; 42(11):1071-1078. PubMed ID: 31486094
[TBL] [Abstract][Full Text] [Related]
28. Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A meta-analysis on 24,268 patients.
Benedetto U; Melina G; Angeloni E; Refice S; Roscitano A; Fiorani B; Di Nucci GD; Sinatra R
Eur J Cardiothorac Surg; 2009 Oct; 36(4):611-5. PubMed ID: 19394857
[TBL] [Abstract][Full Text] [Related]
29. The role of coronary artery bypass surgery versus percutaneous intervention in patients with diabetes and coronary artery disease.
Godoy LC; Ko DT; Rao V; Farkouh ME
Prog Cardiovasc Dis; 2019; 62(4):358-363. PubMed ID: 31377224
[TBL] [Abstract][Full Text] [Related]
30. How to treat diabetic patients with multivesseal disease in the DES era.
Pagnotta P; Cabbavale M; Briguori C
Minerva Cardioangiol; 2006 Oct; 54(5):557-69. PubMed ID: 17019393
[TBL] [Abstract][Full Text] [Related]
31. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
Morrison DA; Sacks J
Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis of three randomized trials and nine observational studies comparing drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary artery disease.
Jang JS; Choi KN; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Urm SH; Chun JH; Kang SJ; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
Am J Cardiol; 2012 Nov; 110(10):1411-8. PubMed ID: 22877423
[TBL] [Abstract][Full Text] [Related]
33. Revascularization in complex multivessel coronary artery disease after FREEDOM. Is there an indication for PCI and drug-eluting stents?
Koskinas KC; Windecker S
Herz; 2016 May; 41(3):224-32. PubMed ID: 27048841
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of multivessel versus culprit-only percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome and multivessel coronary disease.
Jang JS; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Cho KI; Kim BH; Park YH; Je HG
Am J Cardiol; 2015 Apr; 115(8):1027-32. PubMed ID: 25724783
[TBL] [Abstract][Full Text] [Related]
35. Revascularization options: coronary artery bypass surgery and percutaneous coronary intervention.
Kappetein AP; van Mieghem NM; Head SJ
Cardiol Clin; 2014 Aug; 32(3):457-61. PubMed ID: 25091970
[TBL] [Abstract][Full Text] [Related]
36. Stable coronary artery disease: revascularisation and invasive strategies.
Piccolo R; Giustino G; Mehran R; Windecker S
Lancet; 2015 Aug; 386(9994):702-13. PubMed ID: 26334162
[TBL] [Abstract][Full Text] [Related]
37. CABG versus PCI in the treatment of diabetic patients affected by coronary artery disease.
Nicolini F; Agostinelli A; Vezzani A; Benassi F; Gherli T
Int Heart J; 2014; 55(6):469-73. PubMed ID: 25297505
[TBL] [Abstract][Full Text] [Related]
38. Myocardial revascularization strategies in diabetic patients with multi-vessel disease: CABG vs DES-based PCI.
Kassimis G; Patel N; Banning AP
Curr Pharm Des; 2014; 20(28):4589-96. PubMed ID: 24568733
[TBL] [Abstract][Full Text] [Related]
39. Optimal Treatment Strategies in Patients with Chronic Kidney Disease and Coronary Artery Disease.
Volodarskiy A; Kumar S; Amin S; Bangalore S
Am J Med; 2016 Dec; 129(12):1288-1298. PubMed ID: 27476086
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With End-Stage Renal Disease.
Krishnaswami A; Goh ACH; Go AS; Lundstrom RJ; Zaroff J; Jang JJ; Allen E
Am J Cardiol; 2016 May; 117(10):1596-1603. PubMed ID: 27013385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
